DalsnaFinance › IPOs › Krystal Biotech, Inc.
Krystal Biotech, Inc. completed its initial public offering on NASDAQ on September 20, 2017, pricing at $10.00 a share.
| Ticker | KRYS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 20, 2017 |
| Offering price | $10.00 |
| Shares offered | 3,960,000 |
| Total raised | $40M |
Krystal Biotech, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.